Basically, by investing in BioNTech you’re also hitching your wagon to Pfizer, which isn’t a bad thing at all. Association with a drug-making giant means access to resources that smaller companies generally wouldn’t have access to. But wait, it gets even better. On Nov. 20, Pfizer an...
Keller Rinaudo, co-founder and CEO of Zipline, emphasized that delivery to people in remote and hard-to-reach places is a significant challenge for global vaccination. But the partnership with Pfizer and BioNTech has created a solution to combat this roadblock. EU Approves R...
Fauci's comments in a Tuesday interview with MSNBC come a day after Pfizer announced that a vaccine being developed in partnership with BioNTech proved more than 90% effective in preventingCOVID-19in a Phase 3 clinical trial. RELATED:COVID-19 vaccine timeline: A look at what’s ahead ...
In December 2020, a Pfizer and BioNTech partnership (Pfizer–BioNTech) produced one of the first COVID-19 vaccines to receive Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for those aged 16 and over. It was later expanded to include...
Nick Lagunowich, global president of Pfizer emerging markets said the partnership between Biovac and Pfizer has enabled Pfizer to expand its capabilities to locally produce not only the Pfizer-BioNtech Covid 19 vaccine, but also the 13 valent pneumococcal conjugate vaccine included in South Africa’...
Pfizer and BioNTech signed a partnership deal and are aiming for clinical trials to start in the second half of 2022, they said in a joint statement. "The collaboration aims to develop a new mRNA-based vaccine against shingles, leveraging the expertise and resources of both companies," said ...
WASHINGTON - Director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield said on Sunday he has signed the recommendation of a key CDC advisory group to use the COVID-19 vaccine of American drugmaker Pfizer in partnership with German company BioNTech. ...
“We remain committed to moving as quickly and safely as possible to bring this vaccine to more people in Europe, as the deadly virus continues to spread at an alarming rate,” said Albert Bourla, chairman and chief executive officer, Pfizer. “In partnership with the European Commission, memb...
The US government will buy 500 million more doses of the Pfizer/BioNTech COVID-19 vaccine that will be given to around 100 countries via the COVAX donation programme over the next two years. Pfizer and BioNTech are providing 200 million doses this year,
(Yicai Global) March 19 -- The potential Covid-19 vaccine candidate that Pfizer is developing with Germany's BioNTech will not be sold in China because the latter has another partnership with a local player, the US pharmaceutical giant said today. ...